“…These measures are commonly evaluated in menopause studies. 17–21 For a minimum of two weeks before the injection procedure and for six months thereafter, participants recorded the frequency and severity of daily VMS in a paper diary. Participants were instructed to rate each hot flash as “mild” (< 5 minutes, warm, red face, uncomfortable), “moderate” (< 15 minutes, warmth involving neck, ears, head, whole body, with perspiration, clammy skin, dry mouth, tense muscles, tachycardia, irritation, agitation, embarrassment), “severe” (< 20 minutes, warmth described as a raging furnace or burning up, weak, faint, headache, chest heaviness, extreme perspiration, prickling sensation over skin, heart irregularities, anxious, panic attacks) or “very severe” (< 45 minutes, boiling eruption, rolling perspiration, inability to breathe, faint/dizzy, leg/foot cramps, heart irregularities, difficulty functioning, distressed, nausea).…”